UniProt ID | PLCE_HUMAN | |
---|---|---|
UniProt AC | Q9NUQ2 | |
Protein Name | 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon | |
Gene Name | AGPAT5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 364 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Nucleus envelope . Mitochondrion . |
|
Protein Description | Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. Acts on LPA containing saturated or unsaturated fatty acids C15:0-C20:4 at the sn-1 position using C18:1-CoA as the acyl donor. Also acts on lysophosphatidylethanolamine using oleoyl-CoA, but not arachidonoyl-CoA, and lysophosphatidylinositol using arachidonoyl-CoA, but not oleoyl-CoA. Activity toward lysophosphatidylglycerol not detectable.. | |
Protein Sequence | MLLSLVLHTYSMRYLLPSVVLLGTAPTYVLAWGVWRLLSAFLPARFYQALDDRLYCVYQSMVLFFFENYTGVQILLYGDLPKNKENIIYLANHQSTVDWIVADILAIRQNALGHVRYVLKEGLKWLPLYGCYFAQHGGIYVKRSAKFNEKEMRNKLQSYVDAGTPMYLVIFPEGTRYNPEQTKVLSASQAFAAQRGLAVLKHVLTPRIKATHVAFDCMKNYLDAIYDVTVVYEGKDDGGQRRESPTMTEFLCKECPKIHIHIDRIDKKDVPEEQEHMRRWLHERFEIKDKMLIEFYESPDPERRKRFPGKSVNSKLSIKKTLPSMLILSGLTAGMLMTDAGRKLYVNTWIYGTLLGCLWVTIKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MLLSLVLHTYS ----CCHHHHHHHHH | 16.69 | 23663014 | |
9 | Phosphorylation | LLSLVLHTYSMRYLL CHHHHHHHHHHHHHH | 17.09 | 23663014 | |
10 | Phosphorylation | LSLVLHTYSMRYLLP HHHHHHHHHHHHHHH | 6.96 | 23663014 | |
11 | Phosphorylation | SLVLHTYSMRYLLPS HHHHHHHHHHHHHHH | 9.65 | 23663014 | |
14 | Phosphorylation | LHTYSMRYLLPSVVL HHHHHHHHHHHHHHH | 12.16 | 24043423 | |
18 | Phosphorylation | SMRYLLPSVVLLGTA HHHHHHHHHHHCCCC | 25.48 | 24043423 | |
24 | Phosphorylation | PSVVLLGTAPTYVLA HHHHHCCCCCHHHHH | 29.45 | 24043423 | |
27 | Phosphorylation | VLLGTAPTYVLAWGV HHCCCCCHHHHHHHH | 24.65 | 24043423 | |
28 | Phosphorylation | LLGTAPTYVLAWGVW HCCCCCHHHHHHHHH | 7.75 | 24043423 | |
39 | Phosphorylation | WGVWRLLSAFLPARF HHHHHHHHHHHCHHH | 22.90 | 110759125 | |
120 | Ubiquitination | GHVRYVLKEGLKWLP CCHHHHHHHCCCCHH | 39.43 | 21890473 | |
120 | Malonylation | GHVRYVLKEGLKWLP CCHHHHHHHCCCCHH | 39.43 | 26320211 | |
150 | Ubiquitination | RSAKFNEKEMRNKLQ ECCCCCHHHHHHHHH | 58.89 | 21890473 | |
155 | Ubiquitination | NEKEMRNKLQSYVDA CHHHHHHHHHHHHCC | 37.22 | 21890473 | |
164 | Phosphorylation | QSYVDAGTPMYLVIF HHHHCCCCCEEEEEC | 13.45 | 110759131 | |
183 | Acetylation | RYNPEQTKVLSASQA CCCHHHHHCCCHHHH | 40.65 | 26051181 | |
183 | Ubiquitination | RYNPEQTKVLSASQA CCCHHHHHCCCHHHH | 40.65 | 21890473 | |
183 | Malonylation | RYNPEQTKVLSASQA CCCHHHHHCCCHHHH | 40.65 | 26320211 | |
201 | Ubiquitination | QRGLAVLKHVLTPRI HHHHHHHHHHCCHHH | 25.68 | - | |
201 | Acetylation | QRGLAVLKHVLTPRI HHHHHHHHHHCCHHH | 25.68 | 25825284 | |
205 | Phosphorylation | AVLKHVLTPRIKATH HHHHHHCCHHHCHHH | 14.94 | 22210691 | |
209 | Ubiquitination | HVLTPRIKATHVAFD HHCCHHHCHHHHHHH | 48.81 | - | |
221 | Phosphorylation | AFDCMKNYLDAIYDV HHHHHHHHHHHHCEE | 10.63 | 7331141 | |
232 | Phosphorylation | IYDVTVVYEGKDDGG HCEEEEEEECCCCCC | 18.03 | 7331151 | |
253 | Ubiquitination | TMTEFLCKECPKIHI CHHHHHHHHCCCEEE | 65.58 | - | |
257 | Ubiquitination | FLCKECPKIHIHIDR HHHHHCCCEEEEEEE | 59.58 | - | |
290 | Ubiquitination | ERFEIKDKMLIEFYE HHHCCCCHHHHHECC | 30.51 | - | |
296 | Phosphorylation | DKMLIEFYESPDPER CHHHHHECCCCCHHH | 11.60 | 26471730 | |
298 | Phosphorylation | MLIEFYESPDPERRK HHHHECCCCCHHHHH | 24.19 | 26471730 | |
310 | Ubiquitination | RRKRFPGKSVNSKLS HHHCCCCCCCCCHHC | 52.01 | - | |
315 | Ubiquitination | PGKSVNSKLSIKKTL CCCCCCCHHCCCCHH | 40.84 | - | |
321 | Phosphorylation | SKLSIKKTLPSMLIL CHHCCCCHHCHHHHH | 38.61 | 26552605 | |
324 | Phosphorylation | SIKKTLPSMLILSGL CCCCHHCHHHHHHCC | 29.36 | 68739317 | |
329 | Phosphorylation | LPSMLILSGLTAGML HCHHHHHHCCHHHHE | 25.43 | 30257219 | |
332 | Phosphorylation | MLILSGLTAGMLMTD HHHHHCCHHHHECCH | 25.37 | 26552605 | |
338 | Phosphorylation | LTAGMLMTDAGRKLY CHHHHECCHHCCHHH | 20.80 | 26552605 | |
351 | Phosphorylation | LYVNTWIYGTLLGCL HHHHHHHHHHHHHHH | 8.81 | 20049867 | |
353 | Phosphorylation | VNTWIYGTLLGCLWV HHHHHHHHHHHHHEE | 11.22 | 20049867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLCE_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLCE_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLCE_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PLCE_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...